overlay landing page

We have 118 Active Angel Investors in Germany investing in BioTech on Angels Partners

main investor picture
Tony Corbin
Investing in BioTech • Businesses Solutions ...
 Menlo Park , San Fran..., U.S.A. - Israel - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Icelan
Investor Picture
Previous Investments
  • • Vayyar Imaging: $109000000 (Later stage VC)
  • • VDOO: $57000000 (Later stage VC)
  • • Cloudleaf: $26000000 (Later stage VC)
  • • Fakespot: (Series A)
  • • Fakespot: $4000000 (Series A)
  • • Sumatra: $2000000 (Seed)
  • • MRGN: (Pre Seed)
  • • MRGN: (Pre-Seed)
  • • Ash Wellness: $3000000 (Seed)
  • • Ash Wellness: (Seed+)
  • • AppliedXL: $4000000 (Seed)
  • • AssetDash: (Pre Seed)
  • • Tabula: $3000000 (Pre Seed)
  • • Naya: $6000000 (Seed)
  • • Thorium Data: $100000 (Pre Seed)
  • • OpenAxis: $2000000 (Pre Seed)
  • • CACTIVATE: (Pre Seed)
  • • Grin Gaming: (Seed)
  • • Grin Gaming: (Seed)
  • • Docket: (Seed)
  • • Ask Vera: (Seed)
  • • UrsaLeo: (Seed+)
  • • Cactivate: (Pre-Seed)
  • • Clearforce: (Seed)
  • • Paragon Intel: (Seed+)
  • • Intrro: (Seed)
  • • Bazze: (Pre-Seed)
  • • Asset Dash: (Pre-Seed)
  • • Extend: $16000000 (Series A)
  • • OneCell Diagnostics: $16000000 (Series A)
  • • Finicast: $13000000 (Seed)
  • • Very Good Ventures: $3000000 (Series A)
  • • Very Good Ventures: $3000000 (Series A)
  • • Prellis Biologics: $35000000 (Series C)
  • • Prellis Biologics: $15000000 (Series B)
  • • Biomason: $65000000 (Series C)
  • • Home Delivery Service (HDS Global): $5000000 (Series Unknown)
  • • Rizzle: $17000000 (Convertible Note)
  • • EnTribe: $3000000 (Seed)
  • • Atonarp: $50000000 (Series D)
  • • Atonarp: $2000000 (Series B)
  • • Atonarp: $4000000 (Series A)
  • • Boom Supersonic: $50000000 (Series C)
  • • Extend, Inc.: $16000000 (Series A)
  • • Quartic.ai: $2000000 (Seed)
  • • Globality: $27000000 (Series B)
  • • Globality: $10000000 (Series A)
  • • BangDB: (Seed)
  • • Reaction: $10000000 (Series A)
  • • Reaction: $2000000 (Seed)
  • • Shipster: (Seed)
  • • H2O.ai: $9000000 (Series A)
  • • Trove: $5000000 (Series A)
  • • FUTR Corp.: $5000000 (Seed)
  • • Yellowsmith: $850000 (Seed)
  • • Printi: $1000000 (Series A)
  • • GoPro: $88000000 (Series A)

Tony Corbin

Menlo Park - San Francisco Bay Area - California, U.S.A. - Israel - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Icelan

Contact this investors  
Investing In

BioTech • Businesses Solutions • Hardware (& Manufacturing) • Retail (& E-Commerce) • IoT (& Wearables) • A.I. (& Big Data) • Web Security (& Privacy) • Autonomous vehicles (& Cars) • Robotics

Description

Riverwood Capital is a globally-focused private equity firm that invests in high-growth businesses in the technology and services industries, across a variety of verticals and geographies. Riverwood has offices in Menlo Park, CA and New York, NY and currently has more than 20 investments in North America, Latin America and Asia. The firm's current fund has $780 million of committed capital. The final fund close was in April 2011. Riverwood invests in mid-market technology and technology enabled products and services. The firm defines mid-market as approximately $100-$500 million in revenue for product companies, and approximately $25-$150 million in revenue for software and services. Riverwood occasionally invests outside these ranges. Riverwood invests on a global basis, having already invested in the U.S., Israel, Argentina, Chile, and Brazil. The firm's normal investment size ranges from $25-75 million.

main investor picture
Ian Hogarth
Investing in Software (Web Marketplace Saas..) &b...
 London, U.K. - Germany - U.S.A.
Investor Picture
Previous Investments
  • • Tide (Fintech): $10300000 (Later stage VC)
  • • Oriole Networks: $22000000 (Series A)
  • • Proxima Fusion: $22000000 (Seed)
  • • Proxima Fusion: $8000000 (Pre Seed)
  • • Robin AI: $27000000 (Series B)
  • • Robin AI: $11000000 (Series A)
  • • Unitary: $15000000 (Series A)
  • • Unitary: $8000000 (Seed)
  • • Fabric: $1000000 (Pre Seed)
  • • Claimer: $4000000 (Seed)
  • • Condense: $5000000 (Seed)
  • • The Garden: $3000000 (Seed)
  • • Let’s Do This: $60000000 (Series B)
  • • Outverse: $1000000 (Pre Seed)
  • • Heygo: $20000000 (Series A)
  • • Blloc: $2000000 (Seed)
  • • Oto Health: $700000 (Pre Seed)
  • • Phytoform Labs: $6000000 (Seed)
  • • Hofy: $13000000 (Series A)
  • • Hofy: $3000000 (Seed)
  • • Lapse: $1000000 (Seed)
  • • Mojo: $4000000 (Seed)
  • • Numerade: $26000000 (Series A)
  • • Field: $14000000 (Series A)
  • • Medusa: $950000 (Pre Seed)
  • • FabricNano: $13000000 (Series A)
  • • The Lowdown: (Pre Seed)
  • • Thursday: $3000000 (Seed)
  • • Holy Grail: $3000000 (Seed)
  • • Dishpatch: $14000000 (Seed)
  • • Claap: $3000000 (Pre Seed)
  • • Trilo: $1000000 (Pre Seed)
  • • Quix: $3000000 (Seed)
  • • Ruka: $130000 (Pre Seed)
  • • Apheris: $3000000 (Seed)
  • • Omnipresent: $2000000 (Seed)
  • • Ryde: $910000 (Pre Seed)
  • • Puraffinity: $4000000 (Seed)
  • • Breedr: $3000000 (Seed)
  • • Second Nature: $3000000 (Seed)
  • • SonicCloud: $4000000 (Angel)
  • • Cuvva: $2000000 (Seed)
  • • Timekit: $2000000 (Seed)
  • • Tide: $2000000 (Seed)
  • • Charlie: $1000000 (Seed)
  • • Better.co.uk: $2000000 (Seed)
  • • Pact: $3000000 (Series A)
  • • Thread: (Seed)
  • • Pact Coffee:
  • • RingCentral:

Ian Hogarth

London, U.K. - Germany - U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Education • BioTech • AgroTech • CleanTech • HealthTech (& Fitness) • Human Resources • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer

Description

Entrepreneur, Advisor & Investor

Ian Hogarth is a Co-Founder and serves as Chairman at Songkick. Previously he was an Associate Consultant at Bain & Company. He is also an Angel Investor.

main investor picture
Gilad Engel
Investing in BioTech • Analytics
 , Israel - Germany
Investor Picture
Previous Investments
  • • Dreamlines: $18000000 (Later stage VC)
  • • DocPlanner: $15000000 (Later stage VC)
  • • Smartfrog: $15000000 (Early stage VC)
  • • BOOK A TIGER: $8000000 (Later stage VC)
  • • Lemoncat GmbH: $6000000 (Later stage VC)
  • • Klarx: $4660000 (Early stage VC)
  • • Missbeez: $4000000 (Later stage VC)
  • • Osome: $3000000 (Seed Round)
  • • Blackmoon Financial Group: $2500000 (Later stage VC)
  • • AUTO1 Group: $360000000 (Later stage VC)
  • • Mosa Meat: $75000000 (Later stage VC)
  • • VATBox: $20000000 (Later stage VC)
  • • Fourier Optics: $2000000 (Seed)
  • • Joe: $2000000 (Seed)
  • • Gardin: $1000000 (Pre Seed)

Gilad Engel

, Israel - Germany

Contact this investors  
Investing In

BioTech • Analytics

Description

Board Member

main investor picture
Simon Leicht
Investing in BioTech • FinTech (& Financials...
 Munich, Germany
Investor Picture
Previous Investments
  • • Donut Technologies: $1800000 (Seed Round)
  • • Donut (Financial Software): $1800000 (Seed Round)
  • • Cello: $2000000 (Pre Seed)
  • • Zharta: $4000000 (Seed)
  • • re:cap: $2000000 (Pre Seed)
  • • Exakt Health: $590000 (Pre Seed)
  • • Anything World: $1000000 (Seed)

Simon Leicht

Munich, Germany

Contact this investors  
Investing In

BioTech • FinTech (& Financials services) • CleanTech • Blockchain (& Cryptos) • Robotics

Description

Partner at Possible Ventures

main investor picture
Sven Fund
Investing in Software (Web Marketplace Saas..) &b...
 Berlin, Germany
Investor Picture
Previous Investments
  • • Ex Ordo: $3000000 (Seed)
  • • UNFIA: $110000 (Pre Seed)
  • • SciFlow: (Seed)
  • • Zapnito: (Seed)
  • • Journal of Medical Insight (JoMI): $250000 (Seed)
  • • Labiotech.eu: (Seed)
  • • Inkitt: $1000000 (Seed)
  • • Knowledge Unlatched: (Pre Seed)

Sven Fund

Berlin, Germany

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Media • BioTech • HealthTech (& Fitness) • Consumer

Description

General Manager Publisher Solutions at ResearchGate

main investor picture
Steven Jacobs
Investing in BioTech • Hardware (& Manufactu...
 Berlin, Germany - U.S.A.
Investor Picture

Steven Jacobs

Berlin, Germany - U.S.A.

Contact this investors  
Investing In

BioTech • Hardware (& Manufacturing) • A.I. (& Big Data) • DeepTech • Nanotechnology • Consumer • Woman Focused

main investor picture
Angelica Kohlmann
Investing in Software (Web Marketplace Saas..) &b...
 Munich Germany, Germany
Investor Picture

Angelica Kohlmann

Munich Germany, Germany

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Energy • CleanTech • HealthTech (& Fitness) • Mobile • Consumer

Description

Founder @kohlmann-co-ag, @flowerkid • Studied at @university-of-hamburg

main investor picture
Robert Harrison
Investing in Software (Web Marketplace Saas..) &b...
 Munich Germany, Germany
Investor Picture

Robert Harrison

Munich Germany, Germany

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Energy • CleanTech • HealthTech (& Fitness) • Healthcare (& Wellness) • Mobile

Description

Accomplished Intellectual Property Attorney with language skills. Physics and IT backgound.

main investor picture
Ari Massoudi
Investing in Software (Web Marketplace Saas..) &b...
 /Uk, U.K. - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monaco
Investor Picture

Ari Massoudi

/Uk, U.K. - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monaco

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Media • Education • BioTech • FinTech (& Financials services) • Sales (& Marketing) • HealthTech (& Fitness) • AR/VR • Future Of Work • DeepTech • Healthcare (& Wellness) • Consumer • Woman Focused

Description

Biomedical researcher, entrepreneur, turned bio-pharma consultant ... and entrepreneur again.

main investor picture
    Sebastian Prieto
    Investing in BioTech
     /Uk, U.K. - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monaco
    Investor Picture

    Sebastian Prieto

    /Uk, U.K. - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monaco

    Contact this investors  
    Investing In

    BioTech

    Description

    I like to dance

    main investor picture
    Cameron Hibbert
    Investing in Software (Web Marketplace Saas..) &b...
     Frankfurt Germany, Germany
    Investor Picture

    Cameron Hibbert

    Frankfurt Germany, Germany

    Contact this investors  
    Investing In

    Software (Web Marketplace Saas..) • Other • Media • Education • BioTech • FinTech (& Financials services) • Energy • CleanTech • HealthTech (& Fitness) • Cannabis • Healthcare (& Wellness) • LegalTech

    Description

    Technology commercialization executive, MBA.

    main investor picture
      Christoph D. Kauter
      Investing in Software (Web Marketplace Saas..) &b...
       Frankfurt Germany, Germany
      Investor Picture
      Previous Investments
      • • ConCloud: $100000

      Christoph D. Kauter

      Frankfurt Germany, Germany

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • HealthTech (& Fitness)

      Description

      Christoph Kauter is a Co-Founder and serves as Managing Partner at Beyond Capital Partners. He is also an angel investor. He also serves as Chief Executive Officer at TIGThemis Industries Group and as Deputy Chief Executive Officer at Heliad Equity Partners. He is responsible for strategy, investments and finance within TIG. For the past decade, he has gathered deep expertise in capital markets, corporate finance, and private equity. He gained extensive work experience in mergers and acquisitions advisory and Equity Capital Markets at Deutsche Bank and Dresdner Kleinwort Wasserstein in Frankfurt and London. Furthermore, Christoph established and headed the alternative investment business at TFS and Man Group for European power and emissions derivatives trading. Before joining TIG Themis Industries Group as CEO, Christoph worked at a leading German private equity real estate investor as authorized officer and head of corporate finance, capital markets, and investor relations. He holds an MBA degree (Banking and Finance) from Frankfurt School of Finance and Management and is a Certified Real Estate mergers and acquisitions Advisor (European Business School).

      Germany Startup Ecosystem

      Overview

      Germany boasts one of Europe’s leading startup ecosystems, with Berlin being a major hub for innovation. As of 2023, Germany is home to approximately 20,000 startups. The country benefits from strong government support, excellent infrastructure, and a robust industrial base. In 2022, German startups raised around €12 billion in venture capital funding. These factors collectively highlight Germany's dynamic and rapidly evolving startup landscape.

      Size of the Market

      As of 2023, Germany's startup ecosystem encompasses around 20,000 startups. In 2022, these startups attracted approximately €12 billion in venture capital funding. This substantial investment underscores the ecosystem's growth potential and robust nature. The market's size and financial backing reflect its capacity to foster innovation and sustain a competitive edge within Europe and beyond.

      Key Strengths

      Germany's startup ecosystem is characterized by several key strengths, including a strong engineering tradition, high-quality research institutions, and a central location in Europe. The country excels in sectors such as automotive tech, industrial manufacturing, and cleantech. These strengths are bolstered by Germany's robust industrial base and government support, positioning it as a leader in the European startup scene.

      Major Hubs

      Berlin, Munich, and Hamburg are the primary hubs of Germany’s startup ecosystem. Berlin is renowned for its vibrant tech scene, attracting entrepreneurs from around the world. Munich is a key center for deep tech and industrial startups, benefiting from its proximity to major corporations and research institutions. Hamburg excels in logistics and e-commerce, leveraging its strategic location and strong infrastructure. These cities collectively drive Germany's innovation and economic growth.

      Emerging Hubs

      In addition to the major cities, emerging hubs like Frankfurt, Stuttgart, and Cologne are gaining prominence in Germany’s startup ecosystem. Frankfurt is known for its fintech and financial services, Stuttgart for automotive technology and manufacturing, and Cologne for media and entertainment. These emerging hubs are expanding the reach and diversity of Germany’s entrepreneurial landscape, offering new opportunities for innovation and growth.

      Support Systems

      Germany’s startup ecosystem benefits from a strong network of incubators, accelerators, and co-working spaces that provide essential support and resources for entrepreneurs. Programs like the German Accelerator and the High-Tech Gründerfonds have been instrumental in supporting early-stage startups by providing funding, mentorship, and resources. This supportive infrastructure is crucial for nurturing startups and fostering a collaborative entrepreneurial environment.

      Challenges

      Despite its strengths, the German startup ecosystem faces challenges such as bureaucratic hurdles and a relatively risk-averse investment culture. Navigating regulatory frameworks can be time-consuming and complex for startups. Additionally, attracting venture capital can be more difficult compared to more risk-tolerant markets. Addressing these challenges requires strategic efforts and supportive policies to sustain growth and competitiveness.

      Opportunities and Future Outlook

      Germany has significant opportunities for growth in sectors like automotive tech, industrial manufacturing, and cleantech. The country's strong focus on sustainability and green technology drives innovation in renewable energy and environmental technologies. Germany's strategic location in the heart of Europe provides startups with access to a large market and numerous opportunities for international expansion. With continued investment and innovation, Germany's startup ecosystem is poised for further growth, contributing significantly to the global innovation landscape.

      Resilience and Adaptability

      Germany's startup ecosystem demonstrates remarkable resilience and adaptability. The country's commitment to innovation, coupled with strong government and institutional support, enables startups to navigate challenges and capitalize on opportunities. The diverse talent pool and high-quality research institutions attract entrepreneurs and investors alike, ensuring sustained growth and success in the face of global economic shifts and market dynamics.

      How to connect with Angel Investors in Germany?

      In the BioTech industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are prominent figures. These investors focus on startups offering innovative solutions in biotechnology, genomics, and medical research. Esther Dyson, an entrepreneur and investor, looks for biotech startups that have the potential to make significant advancements in healthcare and medicine. Vinod Khosla, founder of Khosla Ventures, invests in high-impact biotech companies with disruptive technologies. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups that push the boundaries of biological science and innovation. To connect with these investors, attend biotech conferences, medical expos, and networking events such as BIO International Convention, JP Morgan Healthcare Conference, and SynBioBeta. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your biotech solution addresses key challenges in healthcare and medical research, such as developing new therapies, improving diagnostic accuracy, or advancing genomic research. Highlight any traction you’ve gained, such as partnerships with research institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as licensing, product sales, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from biotech experts can also enhance your credibility.

      Join the community!
      Connect with investors & startup founders

      Comprehensive Guides to Finding Angel Investors in Germany

      By clicking on "Create Account" you accept our terms of service

      Already have an account?
      Login
      Mike testimonial

      Michael Colin - Founder of The MVMT



      "We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

      Taylor Testimonial

      Taylor Matter - Founder & CEO, Hurdle Apparel



      "Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who invested $200,000 in our brand."

      founder clement

      Clément Perrot - Co-Founder & CEO of Prynt



      "Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


      Create An Account
      Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
      proof notifcation
      32 New StartupsStarted their fundraisingover the last 7 days